GoodRx Holdings Inc (NASDAQ:GDRX) price on Friday, December 27, rose 2.21% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $4.62.
A look at the stock’s price movement, the close in the last trading session was $4.52, moving within a range at $4.48 and $4.645. The beta value (5-Year monthly) was 1.393. Turning to its 52-week performance, $9.26 and $4.09 were the 52-week high and 52-week low respectively. Overall, GDRX moved -2.94% over the past month.
GoodRx Holdings Inc’s market cap currently stands at around $1.76 billion, with investors looking forward to this quarter’s earnings report slated for in January.
Analysts have a consensus estimate of 199.73M for the company’s revenue for the quarter, with a low and high estimate of 199.09M and 200.2M respectively. The average forecast suggests up to a 1.57% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 793.54M, representing a 4.38% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that GDRX is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
16 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 7 analyst(s) rate the stock as a Hold, 9 recommend GDRX as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
GDRX’s current price about -1.95% and -10.81% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 43.54, while 7-day volatility ratio is 4.11% and 4.04% in the 30-day chart. Further, GoodRx Holdings Inc (GDRX) has a beta value of 1.30, and an average true range (ATR) of 0.21. Analysts have given the company’s stock an average 52-week price target of $10, forecast between a low of $3 and high of $45. Looking at the price targets, the low is 35.06% off current price level while to achieve the yearly target high, price needs to move -874.03%. Nonetheless, investors will most likely welcome a -116.45% jump to $10 which is the analysts’ median price.
If we refocus on GoodRx Holdings Inc (NASDAQ:GDRX), historical trading data shows that trading volumes averaged 1.28 over the past 10 days and 1.38 million over the past 3 months. The company’s latest data on shares outstanding shows there are 103.93 million shares.
The 77.24% of GoodRx Holdings Inc’s shares are in the hands of company insiders while institutional holders own 18.00% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 7.44 million on 2024-11-29, giving us a short ratio of 3.68. The data shows that as of 2024-11-29 short interest in GoodRx Holdings Inc (GDRX) stood at 796.9999999999999 of shares outstanding, with shares short falling to 8.69 million registered in 2024-10-31. Current price change has pushed the stock -31.04% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the GDRX stock continues to rise going into the next quarter.
